Nightingale Health Signs $1M LifeArc Proteomics Agreement
The agreement covers proteomics analysis of 10,000 UK Biobank samples using NULISAseq Neuro 220, with data delivered to UK Biobank. It extends a prior $6.5 million study of 60,000 samples.
Nightingale Health Plc signed a $1M agreement with LifeArc to run proteomics on 10,000 UK Biobank samples using NULISAseq Neuro 220, with data delivered to UK Biobank. It extends a prior $6.5M study of 60,000 samples.Material DetailsContext by AI AnalystThis builds on a recent expansion into large…